Antigua and Barbuda
Tuberculosis profile
Population  2012 <1 million
Estimates of TB burden * 2012 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) <0.01 (<0.01–<0.01) 1.4 (1.2–1.5)
Mortality (HIV+TB only) <0.01 (0–<0.01) 0.42 (0–1.8)
Prevalence  (includes HIV+TB) <0.01 (<0.01–<0.01) 4.8 (1.6–9.9)
Incidence  (includes HIV+TB) <0.01 (<0.01–<0.01) 3.9 (3.4–4.4)
Incidence (HIV+TB only) <0.01 (<0.01–<0.01) 1.5 (0.5–3)
Case detection, all forms (%) 87 (77–99)    
TB case notifications 2012        
New cases   (%) Retreatment cases (%)
Smear-positive 1 (33) Relapse 0 (0)
Smear-negative 0 (0) Treatment after failure 0 (0)
Smear-unknown / not done 1 (33) Treatment after default 0 (0)
Extrapulmonary 1 (33) Other 1 (100)
Other 0 (0)      
Total new 3   Total retreatment 1  
           
Other (history unknown)          
Total new and relapse 3   Total cases notified 4  
New cases Smear-positive Smear-negative/ unknown/
not done
Extrapulmonary
M:F ratio      
Age < 15 0 0 0
Laboratories 2012
Is second-line drug susceptibility testing available? Yes, outside
country
Treatment success rate 2011 (%)        
New smear-positive and/or culture-positive 17   Is rifampicin used
throughout treatment for
new patients?
Yes
New smear-negative/extrapulmonary    
Retreatment 50  
TB/HIV 2012 Number (%)
TB patients with known HIV status 4 (100)
HIV-positive TB patients 2 (50)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT) 1 (50)
HIV-positive TB patients on antiretroviral therapy (ART) 2 (100)
HIV-positive people screened for TB 125  
HIV-positive people provided with IPT 1  
Estimates of MDR-TB burden 2012*   New   Retreatment
% of TB cases with MDR-TB 2.2 (1.4–3.1) 14 (4.6–23)
MDR-TB cases among notified pulmonary
TB cases
0 (0–0) 0 (0–0)
Reported cases of MDR-TB 2012 New Retreatment Total
Cases tested for MDR-TB 0 (0%) 0 (0%) 0
Laboratory-confirmed MDR-TB cases 0 0 0
Patients started on MDR-TB treatment     1
Financing TB control 2013
National TB programme budget (US$ millions) <1
***
(Rate per 100 000 population per year)
Mortality graph
___ Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
___ Prevalence

(Rate per 100 000 population per year)
Incidence graph
__ Notifications Incidence
___
___ Incidence (HIV+TB only)

Treatment success rate (%)
tx success graph
__ New smear-positive and/or culture-positive
__ New smear-negative/extrapulmonary __
Retreatment

(Number of patients)
CPT ART graph
__ HIV-positive TB patients
__ on CPT __ on ART

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 * Ranges represent uncertainty intervals Generated: 2014-04-25 Data: www.who.int/tb/data